News & Updates
Filter by Specialty:
First-line serplulimab + chemo ups survival in extensive-stage SCLC
The addition of serplulimab to chemotherapy in the first-line setting improved overall survival (OS) in patients with extensive-stage small cell lung cancer (SCLC), according to results of the ASTRUM-005 trial.
First-line serplulimab + chemo ups survival in extensive-stage SCLC
02 Dec 2022
Age, sex, syphilis risk factors for COVID-19 in PLHIV
Among people living with HIV (PLHIV), young women and patients with active syphilis appeared to be at an elevated risk of contracting COVID-19, according to a cross-sectional study presented at HIV Glasgow 2022.
Age, sex, syphilis risk factors for COVID-19 in PLHIV
30 Nov 2022
Lung fibrosis extent on quantified CT predicts survival in IPF
The extent of fibrotic abnormality on baseline computed tomography (CT), quantified using data-driven texture analysis (DTA), is predictive of outcomes in patients with idiopathic pulmonary fibrosis (IPF), regardless of pulmonary function, suggests a study.
Lung fibrosis extent on quantified CT predicts survival in IPF
29 Nov 2022
Vilobelimab augments treatment armamentarium for critically ill COVID-19 patients
In the phase III part of the PANAMO trial, the anti-C5a monoclonal antibody vilobelimab, when added to standard of care (SoC), improved survival in COVID-19 patients who required invasive mechanical ventilation (IMV).
Vilobelimab augments treatment armamentarium for critically ill COVID-19 patients
29 Nov 2022
Breath-holding may predict adverse outcomes in COVID-19 patients
A higher prediction score in breath-holding is associated with nearly a fivefold increased likelihood of respiratory failure in COVID-19 patients, as well as with greater severity of pulmonary deficits seen in chest imaging, a study has shown.
